Clinical Research Directory
Browse clinical research sites, groups, and studies.
Physician- and Patient-based Barriers to NGS Testing
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Summary
The goal of this study is to improve next-generation sequencing (NGS) testing rates at Johns Hopkins in patients with metastatic prostate cancer. Investigators believe by targeting two barriers, provider-level and patient-level, will improve the testing rate of NGS at Johns Hopkins.
Official title: A Clinical Trial to Address Physician- and Patient-based Barriers to NGS Testing
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
256
Start Date
2026-01-06
Completion Date
2027-09-06
Last Updated
2026-02-03
Healthy Volunteers
No
Conditions
Interventions
Provider-level and patient education at end of study
The provider level component will involve an email to each of the genitourinary medical oncologists at Johns Hopkins with their NGS testing rate from preliminary data and compare this rate to the mean. The initial email will also include the 2025 ASCO guideline recommending somatic testing in virtually all metastatic prostate cancer patients. Providers who do not have baseline NGS testing rates available will also be emailed. Providers will subsequently be emailed their updated NGS testing rate at the conclusion of the study period. Patients will also receive a one-page patient educational material (via email, or mail if no email on file) on advanced prostate cancer that includes education on somatic NGS testing at the end of the study period.
Provider-level and patient-level
In addition to the provider component, patients will also receive a one-page patient educational material (via email, or mail if no email on file) on advanced prostate cancer that includes education on somatic NGS testing. The email will be sent by the MyChart Recruitment Innovation team. Those without email on file will have the same message and attachment sent via mail by our study coordinator.
Locations (1)
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, United States